| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/31/2007 | CA2186260C Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 07/31/2007 | CA2160767C Injectable microdispersions for soft tissue repair and augmentation |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/26/2007 | WO2007084797A1 Chemically modified polycation polymer for sirna delivery |
| 07/26/2007 | WO2007084765A2 Injectable combination therapy for eye disorders |
| 07/26/2007 | WO2007084541A2 Central administration of stable formulations of therapeutic agents for cns conditions |
| 07/26/2007 | WO2007084068A1 Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
| 07/26/2007 | WO2007083875A2 Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof |
| 07/26/2007 | WO2007083772A1 Improvement of affinity of sparingly soluble or insoluble substance for solvent with water-soluble xylan |
| 07/26/2007 | WO2007083763A1 Method for production of emulsion preparation comprising physiologically active peptide, and kit for production of the preparation |
| 07/26/2007 | WO2007083679A1 Novel film-coated tablet |
| 07/26/2007 | WO2007083631A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 07/26/2007 | WO2007083522A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier |
| 07/26/2007 | WO2007083154A1 Amphipathic polymer conjugates for solubilisation of hydrophobic proteins |
| 07/26/2007 | WO2007082936A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances |
| 07/26/2007 | WO2007082897A2 Polysaccharide-cyclodextrin conjugates |
| 07/26/2007 | WO2007082712A1 Long-acting colloidal formulation of insulin and preparation thereof |
| 07/26/2007 | WO2007082698A1 Foam-forming composition |
| 07/26/2007 | WO2007082331A1 Modified macromolecule |
| 07/26/2007 | WO2007052295A3 Aqueous anaesthetic compositions comprising propofol |
| 07/26/2007 | WO2007051743A3 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 07/26/2007 | WO2007049304A3 Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| 07/26/2007 | WO2007030623A3 Bi-modal hyaluronate solution |
| 07/26/2007 | WO2007025274A3 Self-assembling nanoparticles for the treatment of vascular diseases |
| 07/26/2007 | WO2007025142A3 Gel compositions comprising a combination of an antiseptic and an anesthetic agent for treating surface areas in medical and surgical procedures |
| 07/26/2007 | WO2007015107A3 Artificial platelets |
| 07/26/2007 | WO2007006497A3 Solubilsation products of an active ingredient extract |
| 07/26/2007 | WO2006136586A3 N, n-bis- (2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs |
| 07/26/2007 | WO2006102728A3 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 07/26/2007 | WO2006060533A3 Conjugates of 1, 8-bis-naphthalimides with an antibody |
| 07/26/2007 | WO2006055447A3 Nanoparticles having a magnetic core and a cationic organo-silane coating for the delivery of oligonucleotides |
| 07/26/2007 | WO2006034420A3 Multi-purpose bio-material composition |
| 07/26/2007 | US20070173480 Formulations for mediating inflammatory bowel disorders |
| 07/26/2007 | US20070173448 Solution for removing cataracts via liquefracture |
| 07/26/2007 | US20070173437 Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070173424 soap comprising glycerine and dried sapropel; alleviates and/or arrests the symptoms brought about by, or associated with, diseases and/or conditions such as eczema, dermatitis, acne, psoriasis, athlete's foot and various skin allergies |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172518 Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172514 Materials and methods for improving livestock productivity |
| 07/26/2007 | US20070172513 Encapsulation of oxygen sensitive agents |
| 07/26/2007 | US20070172512 administering Lactobacillus paracasei that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier; liver cirrhosis |
| 07/26/2007 | US20070172511 Food Products Comprising a Slowly Digestible or Digestion Resistant Carbohydrate Composition |
| 07/26/2007 | US20070172496 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 07/26/2007 | US20070172473 Corrosion inhibiting mildew remover kit |
| 07/26/2007 | US20070172469 Methods For Inhibiting Viral Replication In Vivo |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | US20070172445 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone |
| 07/26/2007 | US20070172428 Multivalent constructs for therapeutic and diagnostic applications |
| 07/26/2007 | US20070172427 Biofunctionalized quantum dots for biological imaging |
| 07/26/2007 | US20070172422 Exponential pattern recognition based cellular targeting compositions, methods and anticancer applications |
| 07/26/2007 | CA2637931A1 Chemically modified polycation polymer for sirna delivery |
| 07/26/2007 | CA2637635A1 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 07/26/2007 | CA2637564A1 Thimerosal removal device |
| 07/26/2007 | CA2637408A1 Foam-forming composition |
| 07/26/2007 | CA2637359A1 Central administration of stable formulations of therapeutic agents for cns conditions |
| 07/26/2007 | CA2637065A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances |
| 07/26/2007 | CA2636599A1 Modified macromolecule |
| 07/26/2007 | CA2636173A1 Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation |
| 07/25/2007 | EP1811036A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/25/2007 | EP1810714A1 Use of a combination of heroin and naloxon for drug substitution |
| 07/25/2007 | EP1810695A1 Non-aqueous liquid shampoo composition |
| 07/25/2007 | EP1810694A2 Water-soluble compositions of bioactive lipophilic compounds |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810688A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 07/25/2007 | EP1810679A2 Controlled release oxycodone compositions |
| 07/25/2007 | EP1810665A1 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 07/25/2007 | EP1809671A2 Targeted innate immunity |
| 07/25/2007 | EP1809667A1 Peptides for use in the treatment of obesity |
| 07/25/2007 | EP1809339A2 Compounds, kits and methods for use in medical imaging |
| 07/25/2007 | EP1809335A2 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 07/25/2007 | EP1809334A2 Conjugates with enhanced cell uptake activity |
| 07/25/2007 | EP1809333A2 Lipopolymer conjugates |
| 07/25/2007 | EP1809332A2 Compositions for multi-step delivery of hot-spots radiation to cancer cells |
| 07/25/2007 | EP1809331A2 Transepithelial delivery of peptides with incretin hormone activities |
| 07/25/2007 | EP1809330A2 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 07/25/2007 | EP1809329A2 Sustained local anesthetic composition containing prefrably a sugar ester such as saib |
| 07/25/2007 | EP1809291A1 Pharmaceutical compositions for transdermal delivery |
| 07/25/2007 | EP1809274A2 Pharmaceutical composition for rectal or vaginal application comprising a platinum complex |
| 07/25/2007 | EP1809266A2 Anticancer compounds and methods |
| 07/25/2007 | EP1809264A2 Antimicrobial amorphous compositions |
| 07/25/2007 | EP1809259A2 Less abusable pharmaceutical preparations |
| 07/25/2007 | EP1809253A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 07/25/2007 | EP1809250A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 07/25/2007 | EP1809245A2 Therapeutic liposomes |
| 07/25/2007 | EP1809244A2 Retinoid solutions and formulations made therefrom |
| 07/25/2007 | EP1809239A1 Novel composition for easing human child birth |
| 07/25/2007 | EP1725215B1 Method and apparatus for producing carrier complexes |
| 07/25/2007 | EP1496076B1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| 07/25/2007 | EP1427383B1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1370257B1 COMPOSITION FOR THE PREVENTION OF OSTEOPOROSIS consisting of A COMBINATION OF ISOFLAVONES AND POLYUNSATURATED FATTY ACIDS |
| 07/25/2007 | EP1357892B1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 07/25/2007 | EP1187807B1 Bipolar lipids and their use for the delivery of bioactive substances |
| 07/25/2007 | EP1143985B1 Use of lactobacillus salivarius |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP1069912B1 Injectable igf-formulations containing succinate as buffering agent |
| 07/25/2007 | EP1032592B1 Antimicrobial peptides |